Hirsutism, characterized by excessive terminal hair growth in a male-like pattern, affects many women and can influence self image and quality of life. Accurate clinical documentation using the correct ICD 10 code is essential for diagnosis, billing, and care coordination.
Healthcare providers rely on precise coding to capture the underlying cause and severity of hirsutism, ensuring that patients receive appropriate evaluation and management. The following sections outline key coding scenarios, documentation requirements, and related clinical concepts.
| ICD 10 Code | Description | Clinical Context | Billable Specialty |
|---|---|---|---|
| E28.2 | PCOS with hirsutism | Most common endocrine cause; requires metabolic assessment | Endocrinology, Gynecology |
| R22.2 | Localised hypertrichosis | Nonandrogenic, focal areas; may be drug or idiopathic | Dermatology, Primary Care |
| E27.1 | Cushing syndrome with hirsutism | Latexballoon due to cortisol excess; central obesity and striae | Endocrinology |
| E28.3 | Other disorders of androgen excess | Includes adrenal hyperplasia or androgen secreting tumors | Endocrinology |
| L68.0 | Generalized hypertrichosis | Diffuse increase in vellus or terminal hair without androgen pattern | Dermatology |
Diagnostic Criteria and Clinical Evaluation for Hirsutism
Clinicians assess hirsutism using validated scoring systems such as the Ferriman Gallwey scale, documenting terminal hair in nine body areas. A thorough history, including medication review and menstrual patterns, helps differentiate androgen dependent from nonandrogenic causes.
Laboratory evaluation may include total and free testosterone, dehydroepiandrosterone sulfate, and early morning cortisol when Cushing syndrome is suspected. Imaging studies, such as pelvic ultrasound, are considered when clinical or laboratory findings suggest an androgen secreting tumor.
ICD 10 Code Selection Based on Underlying Cause
Selecting the appropriate ICD 10 code for hirsutism depends on the identified etiology and documentation in the medical record. Precise coding improves data accuracy for research and resource allocation.
When hyperandrogenism is confirmed, providers assign codes from the E00 E99 chapter to reflect the specific disorder. For idiopathic or drug related hypertrichosis without androgen excess, codes from the L chapter are more suitable.
Management Strategies and Treatment Goals
Management of hirsutism combines pharmacologic, procedural, and lifestyle approaches tailored to the underlying cause and patient preferences. First line therapy often includes combined oral contraceptives or antiandrogens in appropriate candidates.
Cosmetic hair reduction methods such as laser hair removal, electrolysis, and topical eflornithine may be integrated into care to improve symptoms and patient centered outcomes.
Documentation Requirements for Accurate Coding
Clear documentation is critical to support the correct ICD 10 code for hirsutism and associated conditions. Providers should specify the distribution pattern, severity, and etiologic factors when recording the encounter.
Notes should include results of hormonal testing, relevant imaging findings, and the rationale for treatment selection. Detailed records facilitate medical necessity justification and minimize coding queries or denials.
Quality Improvement and Care Coordination
Optimizing the use of the ICD 10 code for hirsutism enhances communication across specialties and supports data driven improvements in women s health. Ongoing education for coders and clinicians promotes consistent, accurate reporting.
- Verify etiology with clinical and laboratory data before assigning codes
- Use specific codes for underlying disorders such as PCOS or Cushing syndrome
- Document severity, distribution, and treatment response in the medical record
- Coordinate care with dermatology, endocrinology, and gynecology as needed
- Review coding guidelines periodically to align with updates and best practices
FAQ
Reader questions
How do I choose between E28.2 and R22.2 for a patient with hirsutism?
Use E28.2 when hirsutism is part of polycystic ovary syndrome or another androgen excess disorder documented in the endocrine chapter; select R22.2 for localized or generalized hypertrichosis that is nonandrogenic, drug induced, or of unknown origin without a diagnosed androgenic condition.
Can systemic symptoms such as weight gain or menstrual irregularity impact coding?
Yes, associated features help identify the underlying etiology. If hyperandrogenism with menstrual irregularity is documented, E28.2 is appropriate, whereas isolated hair changes without androgenic features may require L68.0 or another hypertrichosis code.
What documentation supports medical necessity for advanced hair removal treatments?
Providers should document the extent of hair growth, impact on quality of life, prior conservative measures, and alignment with clinical guidelines. This supports medical necessity for procedures like laser hair removal when performed as part of a comprehensive management plan.
Are there specific coding guidelines when hirsutism is secondary to a prescribed medication?
If hirsutism is iatrogenic, code the adverse effect of the drug first, followed by a code for hypertrichosis, such as T45.5X5A followed by R22.2, ensuring that the documentation clearly links the condition to the medication.